• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zim Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4284.0
  • ISIN : INE518E01015
80.53 -1 (-1.66%)
  • As on 31 Mar 2025 (EOD)
  • Today’s Low

    80.00
  • Today’s High

    85.29
  • Open

    82.20
  • Perv Close

    81.89
  • 52W Low

    79.49
  • 52W High

    131.40

Key Indicators

  • P/E(TTM)

    27.47

  • Mar.Cap (₹Cr.)

    392.39

  • Div & Yield %

    0.00

  • Book Value(₹)

    48.10

  • Debt-Equity Ratio

    -1.66

  • AGM Date

    28-Mar-2025

  • EPS

    2.92

  • P/E Ratio

    27.47

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    392.39

  • RONW (%)

    7.86

  • ROCE (%)

    9.97

Score Board

  • Equity (₹ in Cr.)

    48.73

  • BV (₹)

    48.10

  • Sales( ₹ in Cr.)

    365.47

  • NP (in Cr.)

    16.77

  • NP Var(%)

    -33.0

  • Div%

    0.0

  • CPS (₹)

    6.50

  • EPS (₹)

    3.40

  • Traded Value (₹ in Lakhs)

    390.78

  • 52 Week High

    131.40

  • 52 Week Low

    79.49

  • Price BSE

    80.0

  • Price NSE

    81.00

  • Market Capital( in Cr.)

    390.78

  • P/C Ratio

    12.30

  • P/E Ratio

    23.20

  • Price Vs.BV

    3.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 365.47 396.53 329.49 303.63 274.32 331.72
Excise Duty 353.56 386.73 324.31 288.33 257.80 322.74
Net Sales 365.47 396.53 329.49 303.63 274.32 331.72
Other Income 4.69 6.43 4.51 2.45 4.66 2.05
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 370.16 402.96 334.00 306.08 278.98 333.77
EXPENDITURE :
Raw Materials 353.56 386.73 324.31 288.33 257.80 322.74
Power & Fuel Cost 353.56 386.73 324.31 288.33 257.80 322.74
Employee Cost 50.81 46.47 38.63 34.48 34.58 48.14
Other Manufacturing Expenses 6.03 5.95 5.24 3.94 6.01 4.54
Selling & Administrative Expenses 51.66 55.69 54.44 43.70 40.96 63.26
Miscellaneous Expenses 6.03 5.95 5.24 3.94 6.01 4.54
Less : Pre-operative Expenses Capitalised :
Total Expenditure 347.12 367.04 314.70 292.32 280.46 311.03
Operating Profit 45.43 38.38 32.90 26.06 29.84 13.85
Interest 6.92 5.58 8.31 10.89 12.65 10.59
Gross Profit 23.04 35.92 19.30 8.58 -1.49 22.74
Depreciation 14.83 16.13 14.84 14.61 13.27 11.14
Profit Before Tax 23.04 35.92 19.30 8.58 -1.49 22.74
Tax 0.77 6.28 3.40 0.01 0.00 4.80
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.45 4.63 2.88 2.95 -3.10 1.82
Reported Net Profit 16.76 25.01 13.01 5.62 1.74 16.01
Extraordinary Items 23.04 35.92 19.30 8.58 -1.49 22.74
Adjusted Net Profit 16.76 25.01 13.01 5.62 1.74 16.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.81
P & L Balance carried down 16.76 25.01 13.01 5.62 1.74 16.01
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 5.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.50
Earnings Per Share-Unit Curr 3.44 5.13 2.67 3.46 1.07 9.93
Book Value 0.00 0.00 0.00 0.00 0.00 0.81
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.81

Shareholding Pattern

  • Promoter Group

    33.26%

  • Public Share Holding

    66.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,207,980 33.26 16,207,980 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,207,980 33.26 16,207,980 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 104,610 0.21 104,610 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 115,780 0.24 115,780 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 220,390 0.45 220,390 5
2] Non Institution
Bodies Corporate 5,213,478 10.70 5,165,478 127
Clearing Members 0 0.00 0 0
Directors of their Relatives 722,537 1.48 722,337 10
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,149,860 4.41 645,352 268
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 453,043 0.93 452,443 388
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,886,040 26.45 12,810,920 53
Individuals holding nominal share capital up to Rs. 1 lakh 8,742,801 17.94 7,808,501 16,580
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,750,160 3.59 1,750,160 1
Sub Total 32,297,444 66.28 29,734,716 17,439
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,725,814 100.00 46,163,086 17,450

Company Background

Zim Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zim Laboratories Ltd
  • BSE Code : 4284.0
  • ISIN : INE518E01015
  • Incorporation Year

    1984

  • Registered Office

    Sadoday Gyan (Gr Floor)
    Opp NADT Nelson Square, Nagpur,
    Maharashtra-440013

  • Telephone

    91-712-2588070

  • FAX

  • Chairman

    Anwar S Daud

  • Managing Director

    Anwar S Daud

  • Company Secretary

    Piyush Nikhadi

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Zim Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zim Laboratories 80.20 370.16 365.47 27.47 9.99
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92